Respiratory Medicine
Volume 103, Issue 12 , Pages 1816-1821 , December 2009

Prognostic value of the 6min walk test in bronchiolitis obliterans syndrome

Received 27 February 2009 ,Accepted 19 July 2009.

References 

  1. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update – A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25:745–755
  2. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med. 2002;166:440–444
  3. Al-Githmi I, Batawil N, Shigemura N, Hsin M, Lee TW, He GW, et al. Bronchiolitis obliterans following lung transplantation. Eur J Cardiothorac Surg. 2006;30:846–851
  4. Cooper JD, Billingham M, Egan T, Hertz MI, Higenbottam T, Lynch J, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 1993;12(5):713–716
  5. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002 Mar;21:297–310
  6. Jackson CH, Sharples LD, McNeil K, Stewart S, Wallwork J. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?. J Heart Lung Transplant. 2002;21(6):658–666
  7. Brugiere O, Pessione F, Thabut G, Mal H, Jebrak G, Leseche G, et al. Bronchiolitis obliterans syndrome after single-lung transplantation: impact of time to onset on functional pattern and survival. Chest. 2002;121(6):1883–1889
  8. Nathan SD, Ross DJ, Belman MJ, Shain S, Elashoff JD, Kass RM, et al. Bronchiolitis obliterans in single-lung transplant recipients. Chest. 1995;107(4):967–972
  9. Lama VN, Murray S, Lonigro RJ, Toews GB, Chang A, Lau C, et al. Course of FEV1 after onset of bronchiolitis obliterans syndrome in lung transplant recipients. Am J Respir Crit Care Med. 2007;175:1192–1198
  10. Zheng L, Whitford HM, Orsida B, Levvey BJ, Bailey M, Walters EH, et al. The dynamics and associations of airway neutrophilia post lung transplantation. Am J Transplant. 2006;6:599–608
  11. Zheng L, Walters EH, Ward C, Wang N, Orsida B, Whitford H, et al. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplant. Thorax. 2000;55:53–60
  12. Riise GC, Anderssion BA, Kjellstrom C, Martensson G, Nilsson FN, Ryd W, et al. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. Eur Respir J. 1999;14:1123–1130
  13. DiGiovine B, Lynch JP, Martinez FJ, Flint A, Whyte RI, Iannettoni MD, et al. Bronchiolitis lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation. J Immunol. 1996;157:4194–4202
  14. Martinu T, Howell DN, Davis RD, Steele MP, Palmer SM. Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients. Chest. 2006;129:1016–1023
  15. ATS Committee on Proficiency Standards for Clinical Function Laboratories. ATS Statement:Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117
  16. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;161:487–492
  17. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168:1084–1090
  18. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012
  19. American Thoracic Society Statement. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144:1202–1218
  20. Lettieri CJ, Browning RF, Shorr AF, Ahmad S, Nathan SD. The distance saturation product: a novel measure for mortality prediction in idiopathic pulmonary fibrosis. Respir Med. 2006;100:1734–1741
  21. Shorr AF, Davies D, Nathan SD. Outcomes for patients with sarcoidosis awaiting lung transplantation. Chest. 2002;122:233–238
  22. Cote CG, Pinto-Plata V, Kasprzyk K, Dordelly LJ, Celli BR. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest. 2007;132:1778–1785
  23. American Thoracic Society Official Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:S77–S120
  24. Chhajed PN, Malouf MA, Tamm M, Spratt P, Glanville AR. Interventional bronchoscopy for the management of airway complications following lung transplantation. Chest. 2001;120:1894–1899
  25. Susanto I, Peters JI, Levine SM, Sako EY, Anzueto A, Bryan CL. Use of balloon-expandable metallic stents in the management of bronchial stenosis and bronchomalacia after lung transplantation. Chest. 1998;114:1330–1335

PII: S0954-6111(09)00246-7

doi: 10.1016/j.rmed.2009.07.011

Respiratory Medicine
Volume 103, Issue 12 , Pages 1816-1821 , December 2009

Article Tools

* Image Usage & Resolution